JAGX JAGUAR HEALTH INC Investments/Divestments 8-K Filing 2024 - Securities Purchase and Exchange Agreements Jaguar Health, Inc. entered into a securities purchase agreement and an exchange agreement, issuing shares of common stock in both transactions. They also announced a licensing transaction for their FDA-approved drug Crofelemer in Eastern Europe.Get access to all SEC 8-K filings of the JAGUAR HEALTH INC